MitraClip was designed to spare patients from open-heart surgery by snaking hardware into the heart through a major vein. Its manufacturer, Abbott, said it offered new hope for people severely ill ...

Moreover, Abbott is an established leader in TEER space with its MitraClip system. We expect the market sentiment toward ABT stock to remain positive surrounding the latest development.

In severe cases, surgery can repair or replace the valve. If patients are not candidates for surgery, doctors can implant a clothespin-like device called a MitraClip that helps the valve close ...

The MitraClip, one of the company’s flagship structural heart devices, has been growing steadily as more doctors adopt non-invasive heart valve repair procedures. Abbott is also betting big on ...

Edwards Lifesciences' Pascal device and its emerging portfolio of transcatheter mitral technologies are likely to put pressure on Abbott's MitraClip franchise over the longer term. Abbott remains ...